Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

April 30, 2006

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG

ABT-510 - Thrombospondin-1 mimetic

Trial Locations (5)

Cancer Therapy and Research Center, San Antonio

Virginia G. Piper Cancer Center, Scottsdale

Arizona Cancer Center, Tucson

Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute, Boston

University of Michigan, Ann Arbor